Every investor in MannKind Corporation (NASDAQ:MNKD) should be aware of the most powerful shareholder groups. With 56% stake, institutions possess the maximum shares in the company. Put another way, ...
TipRanks on MSN
MannKind Completes Acquisition of scPharma
MannKind ( (MNKD) ) just unveiled an announcement.
DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.
(RTTNews) - MannKind Corp. (MNKD), a biopharmaceutical company, on Monday announced that it has appointed Ajay Ahuja as Chief Medical Officer with immediate effect. Ahuja will also take up the ...
DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback